For the year ending 2025-12-31, KPHMW has $24,253,300 in assets. $8,126,764 in debts. $8,696,570 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 8,696,570 | |||
| Short-term investments | 8,392,513 | |||
| Prepaid expenses and other current assets | 1,141,804 | |||
| Collaboration receivables | 1,522,770 | |||
| Tax and other receivables | 1,793,459 | |||
| Prepaid collaboration expenses | 201,332 | |||
| Total current assets | 21,748,448 | |||
| Property and equipment, net | 91,672 | |||
| Restricted cash | 4,566 | |||
| Intangible assets and in-process r&d, net | 2,063,100 | |||
| Operating lease assets with right-of-use | 285,827 | |||
| Other assets | 59,687 | |||
| Total assets | 24,253,300 | |||
| Accounts payable | 1,060,306 | |||
| Accrued collaboration credit | 0 | |||
| Operating lease liabilities | 164,461 | |||
| Accrued expenses | 2,406,731 | |||
| Total current liabilities | 3,631,498 | |||
| Contingent consideration | 2,939,316 | |||
| Deferred tax liability | 102,152 | |||
| Non-current operating lease liabilities | 203,798 | |||
| Deferred collaboration revenue | 1,250,000 | |||
| Total non-current liabilities | 4,495,266 | |||
| Total liabilities | 8,126,764 | |||
| Preferred stock | 4 | |||
| Common stock | 275,289 | |||
| Additional paid-in capital | 170,314,656 | |||
| Accumulated deficit | -154,217,276 | |||
| Accumulated other comprehensive loss | -246,137 | |||
| Total stockholders equity | 16,126,536 | |||
| Total liabilities and stockholders equity | 24,253,300 | |||
KIORA PHARMACEUTICALS INC (KPHMW)
KIORA PHARMACEUTICALS INC (KPHMW)